Does ADALIMUMAB Cause Renal cell carcinoma? 105 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 105 reports of Renal cell carcinoma have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.0% of all adverse event reports for ADALIMUMAB.
105
Reports of Renal cell carcinoma with ADALIMUMAB
0.0%
of all ADALIMUMAB reports
3
Deaths
32
Hospitalizations
How Dangerous Is Renal cell carcinoma From ADALIMUMAB?
Of the 105 reports, 3 (2.9%) resulted in death, 32 (30.5%) required hospitalization, and 3 (2.9%) were considered life-threatening.
Is Renal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 105 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB Cause?
Drug ineffective (71,926)
Pain (37,514)
Arthralgia (35,592)
Rheumatoid arthritis (29,817)
Fatigue (29,420)
Injection site pain (28,679)
Headache (19,891)
Nausea (19,299)
Rash (18,690)
Pain in extremity (18,319)
What Other Drugs Cause Renal cell carcinoma?
CABOZANTINIB S-MALATE (451)
SUNITINIB MALATE (361)
PAZOPANIB (244)
AXITINIB (154)
RANITIDINE (143)
EVEROLIMUS (130)
SORAFENIB (118)
METHOTREXATE (116)
PREDNISONE (101)
TACROLIMUS (98)
Which ADALIMUMAB Alternatives Have Lower Renal cell carcinoma Risk?
ADALIMUMAB vs ADALIMUMAB-AACF
ADALIMUMAB vs ADALIMUMAB-AATY
ADALIMUMAB vs ADALIMUMAB-ADAZ
ADALIMUMAB vs ADALIMUMAB-ADBM
ADALIMUMAB vs ADALIMUMAB-AFZB